With a more favourable environment, NIHON KOHDEN improves to Slightly Positive
NIHON KOHDEN (JP), a company active in the Medical Equipment industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 1 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date February 25, 2022, the closing price was JPY 3,085.00 and its potential was estimated at JPY 3,521.93.Nihon Kohden and its subsidiaries are mainly engaged in the research and development, manufacture and sale of electronic medical equipment. Co.'s principal products include electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for cath labs, diagnostic information systems, instruments that continuously monitor the patient's condition, clinical information systems, defibrillators, automated external defibrillators ("AEDs"), pacemakers, ICDs, ventilators, vagus nerve stimulations ("VNSs"), cochlear implants, automated hematology analyzers, ultrasound diagnostic equipment, basic laboratory equipment, and others.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.